Nonclinical Assessment of Abuse Potential for New Pharmaceuticals

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Reference & Language, Law, International
Cover of the book Nonclinical Assessment of Abuse Potential for New Pharmaceuticals by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780124202160
Publisher: Elsevier Science Publication: July 14, 2015
Imprint: Academic Press Language: English
Author:
ISBN: 9780124202160
Publisher: Elsevier Science
Publication: July 14, 2015
Imprint: Academic Press
Language: English

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug.  By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.

  • Provides a consolidated overview of the complex regulatory landscape
  • Offers best practice methodology for conducting animal studies, including selection of doses and positive control agents that will help you improve your own abuse potential studies
  • Includes real-life examples to illustrate how nonclinical data fit into the submission strategy
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug.  By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.

More books from Elsevier Science

Cover of the book Atlas of Structural Geology by
Cover of the book Gene Probes by
Cover of the book Handbook of Water Purity and Quality by
Cover of the book Microbial Forensics by
Cover of the book Lead-Acid Batteries: Science and Technology by
Cover of the book Advances in Computers by
Cover of the book Advances in Bacterial Pathogen Biology by
Cover of the book The Visual Imperative by
Cover of the book Process Pipe and Tube Welding by
Cover of the book New Perspectives in Adipose Tissue by
Cover of the book Functional Foods by
Cover of the book Functional Neuromarkers for Psychiatry by
Cover of the book PEEK Biomaterials Handbook by
Cover of the book Single-Molecule Enzymology: Nanomechanical Manipulation and Hybrid Methods by
Cover of the book International Review of Cell and Molecular Biology by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy